Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
doi 10.30895/1991-2919-2018-8-4-238-245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SCEEMP

Related search

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Anti-Inflammatory Ellagitannins From Cleidion Brevipetiolatum for the Treatment of Rheumatoid Arthritis

English

Method for Assessing Therapeutic Potential of Anti-Inflammatory Antirheumatic Drugs in Rheumatoid Arthritis

BMJ
1973English

Evaluation of the Clinical and Anti-Destructive Effect of an Anti-B Cell Preparation Depending on Concomitant Therapy With Basic Anti-Inflammatory Drugs and Glucocorticoids in Patients With Rheumatoid Arthritis

Medical Council
2019English

Differences in Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients With Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Sarilumab for the Treatment of Rheumatoid Arthritis

Immunotherapy
OncologyAllergyImmunology
2016English

THU0159 Barriers to Rheumatoid Arthritis Treatment Optimisation: Real-World Data From the Arthritispower Registry

2018English

Role of Anti-Inflammatory and Immunomodulatory Agents in Rheumatoid Arthritis.

Al-Azhar Journal of Pharmaceutical Sciences
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy